[1]
“Assessing Impact of Liberalization on Financial Performance Sustainability of Indian Pharmaceutical Industry using Structure Conduct Performance Model”, TURCOMAT, vol. 12, no. 3, pp. 3085–3091, Apr. 2021, Accessed: May 29, 2026. [Online]. Available: https://www.turcomat.org/index.php/turkbilmat/article/view/1530